0.95Open0.95Pre Close0 Volume2 Open Interest13.00Strike Price0.00Turnover348.35%IV101.01%PremiumOct 18, 2024Expiry Date0.00Intrinsic Value100Multiplier20DDays to Expiry0.95Extrinsic Value100Contract SizeAmericanOptions Type0.3620Delta0.0659Gamma7.31Leverage Ratio-0.0534Theta0.0009Rho2.64Eff Leverage0.0061Vega
LifeStance Health Stock Discussion
TQ2 '24: Net loss: $23.3m Revenue: $312.3m, up 20% YoY Clinician base: Up 14% to 6,984 Visit volumes: Up 15% to 2m Adj. EBITDA: $28.6m, up 103% YoY '24 guidance: Rev. $1.2b-$1.242b, Center Margin $363m-$383m, Adj. EBITDA $90m-$100m.
No comment yet